Aptus Capital Advisors’s Precigen PGEN Stock Holding History

Aptus Capital Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$256K	Buy	44,828 +400	+0.9%	+$1.73K	﹤0.01%	1013
2026 Q1	$172K	Hold	44,428	–	–	﹤0.01%	1046
2025 Q4	$186K	Hold	44,428	–	–	﹤0.01%	1050
2025 Q3	$146K	Hold	44,428	–	–	﹤0.01%	1031
2025 Q2	$63.1K	Hold	44,428	–	–	﹤0.01%	1153
2025 Q1	$66.2K	Buy	44,428 +29	+0.1%	+$46	﹤0.01%	1071
2024 Q4	$49.7K	Hold	44,399	–	–	﹤0.01%	1107
2024 Q3	$42K	Hold	44,399	–	–	﹤0.01%	957
2024 Q2	$70.2K	Hold	44,399	–	–	﹤0.01%	857
2024 Q1	$64.4K	Hold	44,399	–	–	﹤0.01%	867
2023 Q4	$59.5K	Hold	44,399	–	–	﹤0.01%	664
2023 Q3	$63K	Hold	44,399	–	–	﹤0.01%	668
2023 Q2	$51.1K	Hold	44,399	–	–	﹤0.01%	587
2023 Q1	$47.1K	Hold	44,399	–	–	﹤0.01%	569
2022 Q4	$67.5K	Hold	44,399	–	–	﹤0.01%	570
2022 Q3	$94K	Hold	44,399	–	–	﹤0.01%	501
2022 Q2	$59K	Hold	44,399	–	–	﹤0.01%	462
2022 Q1	$94K	Hold	44,399	–	–	﹤0.01%	475
2021 Q4	$165K	Hold	44,399	–	–	0.01%	370
2021 Q3	$222K	Hold	44,399	–	–	0.01%	343
2021 Q2	$289K	Hold	44,399	–	–	0.01%	316
2021 Q1	$306K	Hold	44,399	–	–	0.01%	297
2020 Q4	$452K	Hold	44,399	–	–	0.02%	242
2020 Q3	$155K	Buy	+44,399	New	+$211K	0.01%	303
2020 Q1	–	Sell	-44,399	Closed	-$243K	–	504
2019 Q4	$243K	Hold	44,399	–	–	0.02%	326
2019 Q3	$253K	Hold	44,399	–	–	0.01%	336
2019 Q2	$340K	Buy	+44,399	New	+$239K	0.05%	272

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aptus Capital Advisors's PGEN Position: Q2 2026 in Review

Aptus Capital Advisors increased its Precigen (PGEN) stake by 0.9% in Q2 2026, buying an estimated $1.73K and bringing the position to 44,828 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

Aptus Capital Advisors first reported a position in PGEN in Q2 2019 and has held it in 27 quarters since. The position peaked at $452K in Q4 2020. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Aptus Capital Advisors held 44,828 shares of Precigen worth $256K as of Q2 2026.
Aptus Capital Advisors bought 400 Precigen shares in Q2 2026, an estimated $1.73K.
Precigen made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1013 holding.
Aptus Capital Advisors first reported a position in Precigen in Q2 2019 and has held it in 27 quarters since.
Aptus Capital Advisors's Precigen position peaked at $452K in Q4 2020.
211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.